Metrics to compare | BLISSGVS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBLISSGVSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 50.0x | 29.4x | −0.3x | |
PEG Ratio | 1.98 | 0.27 | 0.00 | |
Price/Book | 5.7x | 2.9x | 2.6x | |
Price / LTM Sales | 6.8x | 4.1x | 2.9x | |
Upside (Analyst Target) | - | 18.6% | 64.3% | |
Fair Value Upside | Unlock | 0.2% | 9.2% | Unlock |
Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. The company offers anti-diabetic, anti-infective, anti-inflammatory, antifungal, antihemorrhoidal, antimalarial, antiseptic, cardiovascular, dermatological, gastrointestinal, gynaecology, neoro/cns, ophthalmic, otc drugs, respiratory, urology, and supplementary drug products, as well as engages in pain management services. It exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.